Description: Amicogen, Inc. operates as an industrial biotechnology company in South Korea and internationally. The company offers specialty enzymes, including CX, SP, etc. for pharmaceutical, food, chemical, and energy industries. It also provides new bio-ingredients, such as N-acetylglucosamine for skin moisturizing and joint health; pinitol/D-chiro-inositol; collagen peptide and collagen tripeptide for skin and health; chitoslim and chitosan oligosaccharides; and lactic acid bacteria, as well as fucoxanthin, curezyme, food enzyme, and bamboo salt. In addition, the company offers K-nutra, a healthcare brand; and KeyClean, a disinfectant brand. Further, it provides protein purification resins. The company was founded in 2000 and is headquartered in Jinju-si, South Korea.
Home Page: www.amicogen.com
64, Dongbu-ro
Jinju-Si,
52621
South Korea
Phone:
82 5 5759 6161
Officers
| Name | Title |
|---|---|
| Mr. Yong Chul Shin | Chief Exec. Officer and Pres |
| Mr. Young- Soo Kim | Sr. Managing Director of Production & Sales |
| Mr. Soo-Dong Kim | Sr. Managing Director of Strategic Planning & Sales |
| Mr. Zhe Piao Ph.D. | Chief of Biotech R&D Center and Director of R&D |
Exchange: KQ
Country: KR
Currency: Korean Won (₩)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 4.6842 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 208 |